We launched COVID Vaccine Facts, a new website with scientific and evidence-based information related to the COVID-19 vaccine development process. More details below, plus a look at the benefits of biotech crops. (663 words, 3 minutes, 18 seconds)
BIO challenges “Most Favored Nation” drug pricing…
It’s another busy day in Washington. In the meantime, we have details on our legal challenge to the Trump administration’s drug pricing plan, as well as a look at a new report on the health impacts of climate change and how sustainable biobased…
BIO's new agenda to promote justice through equity
BIO launched an important new agenda to eliminate racial disparities in the industry and health care delivery. We’ve got the details, in around 670 words, just under 4 minutes.
Closing the week with what BIO’s Dr. Cartier Esham said yesterday about investment in neurodegenerative disease—and BIO’s recommendations for advancing clinical development in this area. Also, details on USDA's new report on the economic benefits of the bioeconomy and a new I am BIO video. (756 words, 3 minutes 46 seconds)
There’s a lot happening on the Hill today, including BIO’s Dr. Cartier Esham testifying on advancing treatments and cures for neurodegenerative diseases, and Senate Ag considering key USDA nominees. Ahead of National Immunization Awareness Month, we also recap a conversation yesterday about how we can advance vaccinations. (893 words, 4 minutes, 27 seconds)
From ag biotech in Mexico, to pandemic preparedness in the U.S., it was a busy day on Capitol Hill yesterday as BIO’s Dr. Michelle McMurry-Heath and Phyllis Arthur testified on these important topics. We have a recap, plus more news from D.C. (868 words, 4 minutes, 20 seconds)
It’s a busy day in Washington, with BIO’s Dr. Michelle McMurry-Heath testifying about Mexico’s treatment of agricultural biotech, and BIO’s Phyllis Arthur testifying about lessons learned from COVID-19. Meanwhile, we have details on the “21st Century Cures Act 2.0” and BIO’s take on how we can best modernize it. (855 words, 4 minutes, 16 seconds)
Starting the last week of July with a look at a recent report on human genome editing from the WHO's Expert Committee, as well as what we know about how to combat vaccine hesitancy. (762 words, 3 minutes, 48 seconds)
ICYMI: African swine fever is making a comeback in Germany—this time in farm pigs. We explain how we could end this disease, as well as recap what BIO’s Dr. Michelle said during a Washington Post event about health equity. (770 words, 3 minutes, 51 seconds)
Lots of newness today: the new COVAX Marketplace, BIO’s new VP for Agriculture and Environment, and more news from Washington. (888 words, 4 minutes, 26 seconds)
Today, we have a quick recap of yesterday’s Senate hearing on the federal COVID-19 response, plus a look at a must-read long-read on how the tide is turning on GMOs and why it matters. (842 words, 4 minutes, 12 seconds)
Today, we look at a recent report that has both good and bad news on cancer deaths in the U.S., as well as how gene editing can make biryani ingredients more sustainable and resilient. (772 words, 3 minutes, 51 seconds)
We start a new week bearing bad news: COVID cases are rising across the U.S., and extreme climate events are increasing around the world. Fortunately, biotech can deliver solutions to both challenges—but we have some work to do to get them where they need to go. (766 words, 3 minutes, 49 seconds)
